AMVUTTRA® (vutrisiran)
www.amvuttra.com
www.amvuttra.com
Amvuttra™ (vutrisiran) is indicated for the treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adults and for treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce cardiovascular mortality, cardiovascular hospitalizations and urgent heart failure visits.
PANTHERx Rare Contact
-
833-432-7275
